{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:22:57Z","timestamp":1759191777071,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jhep.2021.01.016","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T17:58:02Z","timestamp":1611251882000},"page":"232-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-2038","authenticated-orcid":false,"given":"Alberto","family":"Ferrarese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9705-4459","authenticated-orcid":false,"given":"Anna Chiara","family":"Frigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-191X","authenticated-orcid":false,"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.01.016_bib1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.016_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.016_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.cgh.2017.09.017","article-title":"Increased level of interleukin 6 associates with increased 90-day and 1-year mortality in patients with end-stage liver disease","volume":"16","author":"Remmler","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.01.016_bib4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2011.12.030","article-title":"C-reactive protein predicts short-term mortality in patients with cirrhosis","volume":"56","author":"Cervoni","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.01.016_bib5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/liv.13264","article-title":"High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis","volume":"37","author":"Agiasotelli","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.01.016_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2015.06.026","article-title":"Presepsin (sCD14-ST), an innate immune response marker in sepsis","volume":"450","author":"Chenevier-Gobeaux","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.jhep.2021.01.016_bib7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1515\/cclm-2020-1212","article-title":"Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection","volume":"59","author":"Ferrarese","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jhep.2021.01.016_bib8","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.3748\/wjg.v22.i41.9172","article-title":"Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis","volume":"22","author":"Papp","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.016_bib9","first-page":"604","article-title":"Presepsin levels in cirrhotic patients with bacterial infections and\/or portal hypertension-related bleeding, presenting with or without acute kidney injury","volume":"31","author":"Elefsiniotis","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jhep.2021.01.016_bib10","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.dld.2019.05.025","article-title":"Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?","volume":"51","author":"Fischer","year":"2019","journal-title":"Dig Liver Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:43:16Z","timestamp":1759174996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0168827821000271"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.01.016","relation":{},"ISSN":["0168-8278"],"issn-type":[{"type":"print","value":"0168-8278"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.10.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}